Pharmaceutical Technology

JUNE 4, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Mayo Clinic 52

Mayo Clinic Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Mayo Clinic 52

Mayo Clinic Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

Pharmacy Times

JUNE 9, 2025

Tichy, PharmD, MBA, vice chair of pharmacy formulary for Mayo Clinic, explained. Still, confusion remains over the role of pharmacy and therapeutics (P&T) committees in this process. This governance issue is a very hot topic,” Eric M.

Pharmacy Technician 22

Pharmacy Technician Compounding Pharmacies Hospitals Pharmacy Management 22

Putting Patients First Blog

APRIL 30, 2024

Assessment of length and readability of informed consent documents for COVID-19 vaccine trials. Mayo Clinic Proceedings, 96(8) , 2095-2101. He is reachable via e-mail at egascho@nhcouncil.org. Sincerely, Randall L. Rutta Chief Executive Officer i Emanuel, E. and Boyle, C. JAMA Network Open, 4(4). doi:10.1001/jamanetworkopen.2021.10843

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

Pharmacy Times

JUNE 26, 2025

In an interview with Pharmacy Times , Shaji Kumar, MD, consultant and research chair of the Division of Hematology in the Department of Internal Medicine at Mayo Clinic, discussed emerging data from the phase 2 RedirecTT-1 study (NCT04586426). Subscribe Now!

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Vaccines Pharmacy Management 26

Pharmaceutical Technology

APRIL 18, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. These can serve as an important component of a vaccine.

Mayo Clinic 59

Mayo Clinic Immunity Immunization Vaccines 59

Pharmacy Times

JUNE 15, 2025

Following, HR+, HER2- early breast cancer is a common subtype where the cancer cells have estrogen and progesterone receptors but do not have excessive amounts of the HER2 protein, according to Mayo Clinic. Mayo Clinic. Clinicaltrials.gov: NCT05306340. Updated April 15, 2025. Accessed June 13, 2025. News release.

Pharmacy Technician 42

Pharmacy Technician Mayo Clinic Compounding Pharmacies Pharmacy Management 42

pharmaphorum

MAY 11, 2022

According to the Mayo Clinic , the overuse of antibiotics sees around one-third of people taking the treatments when they are neither needed nor appropriate. Second, prevent infections wherever possible, including with vaccines. Why AMR is a threat. And finally, conduct research today so we will have antibiotics tomorrow.

Mayo Clinic 145

Mayo Clinic Vaccines 145

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times at the 2025 Oncology Pharmacists Connect (OPC) meeting, Scott Soefje, PharmD, MBA, BCOP, director of pharmacy at Mayo Clinic, focused on the evolving role of pharmacists in healthcare, highlighting their increasing presence in outpatient settings to enhance efficiency and patient care.

Pharmacy Technician 26

Pharmacy Technician Diabetes Inpatient Compounding Pharmacies 26

Pharmacy Times

JUNE 9, 2025

Mayo Clinic. Akkooi A, Mandala M, Kicinski M, Primary analysis of the EORTC-2139-MG/Columbus-AD trial: A randomized trial of adjuvant encorafenib and binimetinib versus placebo in high-risk stage II melanoma with a BRAF-V600E/K mutation. J Clin Oncol. 43, 2025 (suppl 17; abstr LBA9500). doi:10.1200/JCO.2025.43.17_suppl.LBA9500.

Pharmacy Technician 33

Pharmacy Technician Compounding Pharmacies Pharmacy Management Diabetes 33

pharmaphorum

DECEMBER 15, 2022

Malcolm Macartney is a Medical Adviser for Infectious Diseases and Vaccines at Janssen UK, holding the position since June 2020. Malcolm has dedicated his career to virology and has extensive experience working as a clinical and R&D scientist, researching therapies for viruses, including HIV, HBV, HCV and influenza. Mayo Clinic.

Mayo Clinic 69

Mayo Clinic Hospitals Vaccines 69

pharmaphorum

AUGUST 27, 2020

The preprint data referred to is a Mayo Clinic study used to support the EUA based on data taken from patients treated with plasma under the Expanded Access Programme. Now, tragically, there is zero credibility for the upcoming @US_FDA review of #SARSCoV2 vaccines in the months ahead. The @CDCgov was muzzled months ago.

Mayo Clinic 105

Mayo Clinic Labelling Communication Vaccines 105